Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

AIM movers: Norman Broadbent

CyanConnode raising £5m to accelerate expansion

AIM movers: Sosandar third party deal with Sainsbury and Audioboom misses expectations

Ilika manufacturing deal broadens opportunities for Stereax battery

Aquis weekly movers: TAP Global shares continue to rise

AIM weekly movers: Boost in trading in Plexus Holdings shares

Mayfair Equity Partners buying back control of Seraphine

More disappointment from In The Style

AIM movers: Mirriad Adveritising assesses funding possibilities and DSW hit by M&A delays

Private Equity & Venture Capital

Britain’s fastest growing companies

boohoo revenues continue to decline

Second upgrade for Zotefoams

Maintel hit by higher costs

AIM movers: Kodal Minerals lithium mine finance deal and ex-dividends

Gateley continues to grow organically

AIM movers: Quantum Blockchain mining and another disappointment for IOG

CML Microsystems acquires California base

AIM movers: Tower Resources rising and Unbound hit by postal strikes

AIM movers: Tungsten West Hemerdon update and destocking hits IQE

Aquis weekly movers: KR1 recovers to November levels

AIM weekly movers: Share trading surge at Light Science Technologies

AIM movers: Morses Club recovers and Applied Graphene stretches out cash

Likewise revenues ahead of expectations

AIM movers: Portmeirion sales ahead and ex-dividends

AIM movers: Deltic Energy well news and Pelatro continues to decline

AT85 Global Mid-Market Infrastructure launches offer

Marks Electrical outstrips rivals

AIM movers: Katoro Gold appoints nomad and Nanosynth discount

Bookings surge for Osirium Technologies

Hydrogen Utopia International makes standard switch

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020